Abstract: Compounds of formula (I) or a pharmaceutically acceptable salt thereof wherein: V is selected from the group consisting of a covalent bond and CH2; W is selected from the group consisting of a covalent bond, CH2 and CH2CH2; X is selected from the group consisting of a covalent bond and CH2; Y is selected from the group consisting of a covalent bond, CH2, and CH2CH2; Z is selected from the group consisting of CH2, CH2CH2, and CH2CH2CH2; L1 is selected from the group consisting of a covalent bond and (CH2)n; n is 1-5; R1 is selected from the group consisting of (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), and (l); R2 is selected from the group consisting of hydrogen, alkoxycarbonyl, alkyl, aminoalkyl, aminocarbonylalkyl, benzyloxycarbonyl, cyanoalkyl, dihydro-3-pyridinylcarbonyl, hydroxy, hydroxyalkyl, phenoxycarbonyl, and -NH2; are useful for controlling synaptic transmission in mammal.
| # | Name | Date |
|---|---|---|
| 1 | in-pct-2001-00831-mum-form 19(17-5-2004).pdf | 2018-08-08 |
| 2 | in-pct-2001-00831-mum-correspondence(ipo)-(27-1-2010).pdf | 2018-08-08 |
| 3 | in-pct-2001-00831-mum-correspondence(1-8-2002).pdf | 2018-08-08 |
| 4 | abstract1.jpg | 2018-08-08 |